Preliminary data on prednisone effectiveness in children with Sydenham chorea

被引:12
|
作者
Favaretto, Elena [1 ]
Gortani, Giulia [2 ]
Simonini, Gabriele [3 ]
Pastore, Serena [2 ]
Di Mascio, Alberto [1 ]
Cimaz, Rolando [3 ]
Taddio, Andrea [1 ,2 ]
机构
[1] Univ Trieste, Piazzale Europa 2, I-34100 Trieste, Italy
[2] Inst Maternal & Child Hlth IRCCS, Burlo Garofolo Via Istria 65-1, I-34100 Trieste, Italy
[3] Univ Florence, Rheumatol Unit, Anna Meyer Childrens Hosp, Viale Piefaccini 24, I-50139 Florence, Italy
关键词
Acute rheumatic fever; Sydenham chorea; Prednisone; Treatment response; RHEUMATIC-FEVER; JONES CRITERIA; DIAGNOSIS;
D O I
10.1007/s00431-020-03574-y
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The objective of the study is to evaluate the efficacy of corticosteroids in Sydenham chorea. This is a retrospective observational study. Clinical information of children with Sydenham chorea were collected. Outcome of Sydenham chorea was evaluated in consideration of presence or absence of corticosteroid therapy. Thirty patients were enrolled. A total of 15 were treated with prednisone, 15 received symptomatic drugs or no treatment. Patients who were treated with prednisone showed faster improvement (4 vs 16 days; p = 0.002) and shorter median time of remission (30 vs 135 days; p < 0.001). Conclusion: Our study showed that corticosteroid therapy is an effective treatment of Sydenham chorea.What is Known:center dot Steroid treatment in Sydenham chorea is widely used but it is not standardized.center dot Few manuscript report a beneficial use of steroids in Sydenham chorea if compared with no treatment.What is New:center dot Steroid treatment seems to be effective in both clinical remission and clinical improvement of symptoms among patients with Sydenham chorea.center dot Steroid treatment seems to be superior to conventional treatment.
引用
收藏
页码:993 / 997
页数:5
相关论文
共 50 条
  • [31] Magnetic resonance imaging in Sydenham chorea
    Giovanni Castelnovo
    Dimitri Renard
    Acta Neurologica Belgica, 2012, 112 : 397 - 398
  • [32] Sydenham Chorea in Sudan; Presentation Panorama
    Ibrahim, Etedal Ahmed A.
    Mohamed, Rogia Hussein
    Ahmed, Khabab Abbasher Hussien Mohamed
    Mohamed, Malaz Tarig AbdAlla
    Eljack, Mohammed Mahmmoud Fadelallah
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2023, 19 : 1657 - 1663
  • [33] Efficacy of levetiracetam in the treatment of Sydenham chorea
    Direk, Meltem
    Epcacan, Serdar
    Epcacan, Zerrin
    Yildirim, Didem Derici
    Okuyaz, Cetin
    PEDIATRICS INTERNATIONAL, 2020, 62 (11) : 1264 - 1268
  • [34] Sydenham's chorea in childhood.
    Ghram, N
    Allani, C
    Oudali, B
    Fitouri, Z
    Ben Becher, S
    ARCHIVES DE PEDIATRIE, 1999, 6 (10): : 1048 - 1052
  • [35] Treatment of Sydenham Chorea With Intravenous Immunoglobulin
    Walker, Kathleen
    Brink, Anita
    Lawrenson, John
    Mathiassen, Wendy
    Wilmshurst, Jo M.
    JOURNAL OF CHILD NEUROLOGY, 2012, 27 (02) : 147 - 155
  • [36] Obsessive-compulsive symptoms among patients with sydenham chorea
    Asbahr, FR
    Garvey, MA
    Snider, LA
    Zanetta, DM
    Elkis, H
    Swedo, SE
    BIOLOGICAL PSYCHIATRY, 2005, 57 (09) : 1073 - 1076
  • [37] Corticosteroid Treatment in Sydenham Chorea: A 27-Year Tertiary Referral Center Experience
    Cappellari, Alberto Maria
    Rogani, Greta
    Filocamo, Giovanni
    Petaccia, Antonella
    CHILDREN-BASEL, 2023, 10 (02):
  • [38] Persistent Sydenham's chorea is not associated with sustained lymphocyte dysfunction
    de Lima Torres, Karen Cecilia
    Rocha, Natalia Pessoa
    de Rezende, Vitor Bortolo
    Dutra, Walderez Ornelas
    Gollob, Kenneth John
    Cardoso, Francisco
    Teixeira, Antonio Lucio
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2016, 74 (01) : 5 - 9
  • [39] Sydenham chorea in a 5-year-old Saudi patient
    Al-Mendalawi, Mahmood D.
    NEUROSCIENCES, 2015, 20 (01) : 69 - 69
  • [40] Sydenham's chorea: an update on pathophysiology, clinical features and management
    Bastos Vasconcelos, Luiz Paulo
    Vasconcelos, Marcelle Cristina
    Pereira Nunes, Maria Do Carmo
    Teixeira, Antonio Lucio
    EXPERT OPINION ON ORPHAN DRUGS, 2019, 7 (11): : 501 - 511